Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer

31 Mar 2018

Abstract excerpt

Peritoneal dissemination is the most common metastatic pattern in advanced gastric cancer (GC) and has a very poor prognosis. However, its molecular mechanism has not been elucidated. Our study investigated genes associated with peritoneal dissemination of GC. We performed combined expression analysis of metastatic GC cell lines and identified Procollagen-lysine, 2-oxoglutarate 5-dioxygenase2 (PLOD2) as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Cancer Cells and Metastasis
Share to Cancer, Hypoxia, and Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29603227
DOI: 10.1002/ijc.31410

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancerPMID 29603227Read ↗

Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal DisseminationSemantic proximity Read ↗

PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic CharacteristicsSemantic proximity Read ↗

The PLOD2 promotes tumor progression in colorectal cancer through the PI3K-AKT pathwaySemantic proximity Read ↗

Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases.Semantic proximity Read ↗

Representing ECM composition and EMT pathways in gastric cancer using a new metastatic gene signatureSemantic proximity Read ↗

Role of extra cellular proteins in gastric cancer progression and metastasis: an updateSemantic proximity Read ↗

MFAP5+ Cancer-associated fibroblasts promote EMT in gastric cancer via lactylation modification leading to CT-detected extramural venous invasionSemantic proximity Read ↗

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.Semantic proximity Read ↗

Characterization of Procollagen-lysine, 2-oxoglutarate 5-dioxygenases as Therapeutic Targets in a Pan-Cancer StudySemantic proximity Read ↗

Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancerSemantic proximity Read ↗

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer.Semantic proximity Read ↗

A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.